Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2009 Aug;9(8):39-41.
doi: 10.1080/15265160902948330.

Enhancing informed consent in clinical trials and exploring resistances to disclosing adverse clinical trial results

John D Banja  1 , Boadie Dunlop
Affiliations
Comment

Enhancing informed consent in clinical trials and exploring resistances to disclosing adverse clinical trial results

John D Banja et al. Am J Bioeth. 2009 Aug.
No abstract available

PubMed Disclaimer

Comment on

Similar articles

See all similar articles

References

    1. Brendel DH, Miller FG. A plea for pragmatism in clinical research ethics. American Journal of Bioethics. 2008;8(4):24–31. - PubMed
    1. Dunlop B, Banja J. A renewed, ethical defense of placebo-controlled trials of new treatments for major depression and anxiety disorders. Journal of Medical Ethics. 2009;35(6) - PMC - PubMed
    1. Freedman A, Fuks A, Weijer C. Demarcating research and treatment: A systematic approach for the analysis of the ethics of clinical research. Clinical Research. 1992;40:653–660. - PubMed
    1. Liao SM, Sheehan M, Clarke S. The duty to disclose adverse clinical trials results. American Journal of Bioethics. 2009;9(8):24–32. - PubMed
    1. Miller FG, Brody H. What makes placebo-controlled trials unethical? American Journal of Bioethics. 2002;2:3–9. - PubMed

Publication types